Clinical Predictors of Response to Treatment With Tofacitinib (Janus Kinase Inhibitor) in Patients With Ankylosing Spondylitis. IJBR 2025, 3 (4), 175-181. https://doi.org/10.70749/ijbr.v3i4.1020.